Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0100
-0.0005 (-4.76%)
Jun 19, 2026, 3:47 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 21.24 million as of June 18, 2026. Its market cap has increased by 109.81% in one year.
Market Cap
21.24M
Enterprise Value
19.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 21.24M, an increase of 74.57%. That is a compound annual growth rate of 2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 21.24M | -10.15% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imugene | 39.50M |
| Patrys | 30.66M |
| EZZ Life Science Holdings | 23.77M |
| Noxopharm | 23.66M |
| NeuroScientific Biopharmaceuticals | 21.95M |
| Neurotech International | 21.08M |
| Proteomics International Laboratories | 19.82M |
| Opthea | 19.15M |